Clinical Trial Update: BM-MNC and UCMSC for Type 2 Diabetes Mellitus Patients [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update describes BM-MNC and UCMSC therapy for type 2 diabetes mellitus in Phase 1/2 studies; no results or status disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• BM-MNC
• UCMSC (umbilical cord mesenchymal stem cells)

Snippet

Sponsor: Indonesia University | Conditions: T2D | Phase 1, Phase 2 | Status: UNKNOWN